BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lercanidipine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Lercanidipine\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07020104-8708@assetmemo.bio
DTSTAMP:20261121T005713Z
DTSTART;VALUE=DATE:20391201
DTEND;VALUE=DATE:20391202
SUMMARY:Lercanidipine: Phase na readout est. (NCT07020104)
DESCRIPTION:Lercanidipine\, phase na.\nStudy: The Role of Skin Sodium Accum
 ulation in Chronic Kidney Disease\nEstimated primary completion: 1 Decembe
 r 2039. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/lercanidipine
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT070
 20104
URL:https://assetmemo.bio/drug/lercanidipine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
